TEMN Medicina Nuclear flashcards
TEMN Medicina Nuclear · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Effective half-life formula
- One divided by effective half-life equals one divided by physical half-life plus one divided by biological half-life. Effective half-life is always shorter than either component and determines retained dose.
- Technetium-99m properties
- A pure gamma emitter with a 140 keV photopeak and a 6-hour physical half-life, produced from a molybdenum-99 generator. Its energy suits low-energy high-resolution collimators and sodium iodide crystals.
- Fluorine-18 half-life
- Approximately 110 minutes, decaying by positron emission. This permits transport between cyclotron and imaging sites while requiring rapid, scheduled workflows and same-day labeling of FDG.
- Radiochemical purity
- The fraction of total radioactivity present in the intended chemical form. It is measured by chromatography and must be verified before administration because impurities alter biodistribution and increase unnecessary dose.
- Radionuclide purity
- The fraction of activity originating from the intended radionuclide rather than contaminating isotopes. It is assessed by gamma spectroscopy and is critical for generator eluates such as technetium-99m.
- Collimator function
- A lead or tungsten device with holes that restricts incoming photons to near-parallel paths, defining the field of view and spatial resolution. Hole size and septal thickness trade resolution against sensitivity.
- Photopeak energy window
- A pulse-height analyzer setting that accepts counts within a percentage range around the photopeak, typically 15 to 20 percent for technetium-99m. It reduces scatter while retaining most true events.
- OSEM reconstruction
- Ordered-subset expectation maximization is an iterative SPECT and PET reconstruction method that models attenuation, scatter, and detector response, improving image quality and quantitative accuracy over filtered back-projection.
- Attenuation correction rationale
- Photons from deep structures are absorbed before reaching the detector, causing false defects. Correction using CT or transmission sources restores uniform counts in homogeneous regions such as the myocardium.
- FDG patient preparation
- Fasting for at least four to six hours, avoidance of strenuous exercise, and blood glucose measurement before injection. These steps suppress physiologic myocardial and muscular uptake and improve lesion contrast.
- Physiologic FDG distribution
- Normal uptake includes brain cortex, liver, spleen, bone marrow, kidneys, bladder, tonsils, and salivary glands. Myocardial uptake varies with fasting state and should not be mistaken for disease.
- Reversible perfusion defect
- A myocardial region with reduced uptake on stress imaging that normalizes at rest, indicating stress-induced ischemia. A defect present at both stress and rest represents scar or infarction.
- Ventilation-perfusion mismatch
- A segmental perfusion defect with preserved ventilation on a V/Q scan, indicating pulmonary embolism. Matched defects more often reflect parenchymal lung disease such as chronic obstructive disease.
- Three-phase bone scan
- Sequential blood flow, blood pool, and delayed images after technetium-99m MDP injection. It distinguishes hyperemia and inflammation from osteoblastic bone remodeling and helps evaluate prosthetic infection.
- Superscan appearance
- Diffuse intense skeletal uptake with faint or absent renal and soft-tissue visualization, seen in widespread metastases or metabolic bone disease. It can mask lesions by saturating the display scale.
- Sentinel lymph node technique
- Injection of technetium-99m labeled colloid around a tumor, followed by lymphoscintigraphy and intraoperative gamma probe detection. It identifies the first draining node for targeted biopsy.
- Renal tracer MAG3
- Technetium-99m mercaptoacetyltriglycine is secreted by renal tubules and estimates effective renal plasma flow. It provides high target-to-background images even in impaired renal function.
- DMSA renal scan
- Technetium-99m dimercaptosuccinic acid binds to proximal tubular cells, giving cortical images. It detects scars, pyelonephritis, and differential renal function in children and adults.
- Radioiodine therapy principle
- Iodine-131 concentrates in thyroid tissue via the sodium-iodide symporter. Beta emissions deliver therapeutic dose to hyperplastic or neoplastic thyroid cells while gamma emissions permit imaging.
- Lutetium-177 DOTATATE
- A peptide receptor radionuclide therapy targeting somatostatin receptors in neuroendocrine tumors. It delivers beta radiation to receptor-expressing cells and requires dosimetry and renal protection.
- Radium-223 mechanism
- A calcium mimetic alpha emitter that localizes to bone metastases in castration-resistant prostate cancer. Alpha particles cause dense local DNA damage with limited marrow exposure compared with beta emitters.
- Absorbed dose unit
- The gray equals one joule per kilogram of tissue. It quantifies energy deposited by radiation and is converted to equivalent and effective dose using radiation and tissue weighting factors.
- Effective dose concept
- A whole-body dose surrogate that sums tissue-absorbed doses weighted by radiosensitivity. It allows comparison of stochastic risk across different imaging procedures and radionuclides.
- Occupational dose limit
- Twenty millisieverts per year averaged over five years, with no single year exceeding fifty millisieverts. The lens and extremity limits are higher and apply to specific tissues.
- Inverse-square law
- Radiation exposure from a point source decreases with the square of distance. Doubling the distance from a syringe or patient reduces exposure rate to one quarter.
- Stochastic radiation effects
- Cancer and heritable effects for which probability rises with dose but no threshold exists. Severity is not dose-dependent, and risk is estimated using the linear no-threshold model.
- Deterministic radiation effects
- Tissue reactions such as skin erythema, cataract, and marrow suppression that occur only above threshold doses. Severity increases with dose and can be prevented by dose limits.
- Dose calibrator quality control
- Daily constancy and accuracy checks plus periodic linearity and geometry testing verify activity measurement. Errors propagate directly into administered activity and patient dosimetry.
- Gamma camera uniformity test
- A flood field image assesses count uniformity across the detector. Intrinsic uniformity is measured without a collimator, while extrinsic uniformity includes the collimator response.
- Pregnancy screening before tracer
- Question women of reproductive age about last menstrual period and possible pregnancy before administering radiopharmaceuticals. Fetal dose and alternative imaging should be discussed when pregnancy is possible.
- Breastfeeding interruption
- The required pause after a radiopharmaceutical depends on its half-life and excretion. Technetium agents usually require hours, whereas iodine-131 generally requires cessation of breastfeeding.
- Radiopharmaceutical extravasation management
- Stop the injection, apply a cold compress, elevate the limb, and record activity and time. Local dose is estimated and the site is monitored for skin reaction.